J. Puente, S. Alonso, F. Gascón, B. Ponte, D. Fuente
{"title":"基于实物期权价值的创新与研发战略管理模型:制药企业放弃与扩大临床试验的选择","authors":"J. Puente, S. Alonso, F. Gascón, B. Ponte, D. Fuente","doi":"10.1007/978-3-030-70296-0_75","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":272924,"journal":{"name":"Transactions on Computational Science and Computational Intelligence","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Model for the Strategic Management of Innovation and R&D Based on Real Options Valuation: Assessing the Options to Abandon and Expand Clinical Trials in Pharmaceutical Firms\",\"authors\":\"J. Puente, S. Alonso, F. Gascón, B. Ponte, D. Fuente\",\"doi\":\"10.1007/978-3-030-70296-0_75\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":272924,\"journal\":{\"name\":\"Transactions on Computational Science and Computational Intelligence\",\"volume\":\"11 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transactions on Computational Science and Computational Intelligence\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/978-3-030-70296-0_75\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transactions on Computational Science and Computational Intelligence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-3-030-70296-0_75","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Model for the Strategic Management of Innovation and R&D Based on Real Options Valuation: Assessing the Options to Abandon and Expand Clinical Trials in Pharmaceutical Firms